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Introduction 
 
An age-related decline in cognitive ability is noted in the writings of Ancient Egyptian, Roman 
and Greek authors, dementia has only been considered as a pathological process since the 
17th Century. Since then, the emergence of psychiatric classification, the discovery of 
biomarkers and the development of individual aetiological criteria have contributed to the 
ongoing evolution of the dementia concept, perhaps best evidenced by the serial revisions of 
the dementia syndrome in successive editions of International Classification of Diseases 
(ICD) and the Diagnostic and Statistical Manual of Mental Disorders (DSM). 
 
Despite its rise to prominence in medical, social, and political agendas alike, dementia 
remains under-recognised, particularly in the acute hospital setting; Sampson et al. (2009) 
reported that 42% of acute medical admissions over 70 years old had dementia, although 
only half of these cases had been formally diagnosed. 
 
This review discusses key components of the diagnostic process for dementia, important 
differential diagnoses, and considers rating scales and tools which aid the assessment in the 
acute hospital environment. 
 
 
Clinical Assessment 
 
Despite the evolution of dementia over the past century, the core characteristics described 
by Emil Kraepelin remain: progressive cognitive impairment (representing a decline in 
previous abilities) sufficient to affect everyday functioning that persists, differentiating 
dementia from the more acute, and usually transient, impairments of delirium.  
 
The presence or absence of the dementia syndrome must be determined before 
consideration is given to the main diagnostic subtypes: In a general hospital setting, the 
identification and diagnosis of the dementia syndrome is usually best attempted before 
consideration is given to subtype diagnosis later in a specialist setting. The main diagnostic 
subtypes are Alzheimer’s Disease (AD), Vascular Dementia (VaD), Dementia with Lewy 
bodies (DLB) and Frontotemporal Dementia (FTD). Whilst this review does discuss relevant 
features of each of these, an understanding of subcategorization subtypes are is best 
achieved by consulting their respective criteria (McKhann et al., Román et al., 1993; McKeith 
et al., 2005; 2011; Rascovsky et al., 2011). 
 
Central to dementia diagnosis is a comprehensive clinical history, utilising as many sources 
of information as possible. No single neuroimaging investigation or cognitive test is sufficient 
for making a dementia diagnosis. In particular, retrieval of an accurate collateral history is 
essential, as the necessity to demonstrate evidence of a decline from previous cognitive 
ability and functioning requires a thorough understanding of the patient’s premorbid state. 
 
Patients in whom dementia is suspected should be referred to specialist memory 
assessment services (National Institute for Clinical Excellence, 2006), often provided by 
mental health and geriatric medicine teams.  These services provide multidisciplinary 
person-centred care to support patients and their carers through all stages from diagnosis to 
planning for the future.   
 
 
Cognitive impairment 
 
  
Although amnesia was always previously a required deficit for dementia diagnosis, this is no 
longer the case. Neither the National Institute on Ageing-Alzheimer’s Association (NIA-AA) 
nor DSM-5 criteria require the presence of amnesia for a diagnosis of all-cause dementia to 
be made; rather, impairment in any two of five cognitive domains is sufficient (Fig 1). 
Assessment of deficits in these domains is facilitated by the use of cognitive rating scales 
(Figure 1). Despite these changes to criteria, however, retrospective memory loss remains, 
clinically, the most characteristic impairment of dementia. 
 
- impaired ability to acquire and remember new information; 
- impaired reasoning and handling of complex tasks, poor judgement; 
- impaired visuospatial abilities; 
- impaired language function; and 
- changes in personality, behaviour or comportment. 
Fig 1. Impairment in two of the five cognitive domains listed by NIA-AA is required for 
dementia diagnosis (McKhann et al., 2011).  
Of the many cognitive rating scales available, only the Abbreviated Mental Test Score 
(AMTS)(Jitapunkul et al., 1991) had more than a single study examining its properties 
included in a recent meta-analysis for dementia screening in general hospital inpatients, with 
a sensitivity of 81%, and specificity of 84% reported (Jackson et al., 2013). Shorter than the 
Folstein Mini-mental state examination (MMSE) (Folstein et al., 1975), it is also freely 
available to use without the copyright restrictions that the MMSE has been subject to in 
recent years. 
The MMSE nevertheless remains the most commonly used cognitive measurement in 
clinical practice, though is better suited to assessment within specialist services.  It is 
succinct and covers most of the necessary domains but, along with other cognitive scales, 
does not have a cut-off score sufficient for diagnosis. The MMSE poorly assesses frontal 
lobe executive functioning and so the Clock Drawing Task is frequently used as an 
adjunct. The Montreal Cognitive Assessment (MoCA) (Nasreddine et al., 2005) is 
comparable in length to the MMSE but also includes frontal lobe tests and is more sensitive 
to mild cognitive impairment (MCI). The Addenbrooke's Cognitive Examination III (Hsieh et 
al., 2013) offers a much more comprehensive account of cognitive function, providing 
subscores for respective domains.  However, it is considerably longer and more challenging, 
making it less suitable for routine use in the acute medical environment.  
 
Functional impairment 
 
Like cognitive ability, functional impairment must be demonstrated as a decline from the 
patient’s baseline functioning and is thus best informed by a collateral history. Successive 
iterations of diagnostic criteria have lowered the degree of impairment required to satisfy 
functional impairment; where impairment in basic activities of daily living (ADLs) (washing, 
dressing etc.) had previously been necessary, loss of independence in more complex 
instrumental ADLs, like household financial management or navigating public transport, can 
now represent impairment sufficient to meet a diagnosis of dementia (McKhann et al., 2011). 
Again, rating scales can help to identify the presence of functional impairments. The Bristol 
Activities of Daily Living Scale (Bucks et al., 1996) can aid with quantifying patients’ 
functional ability.  As for cognitive ability, clinical judgement is required to determine whether 
or not reported deficits represent a decline in ability.  For example, it is not uncommon for 
tasks like meal preparation or financial management to have been the domain of the 
patient’s spouse prior to the onset of cognitive impairment, and therefore not a meaningful 
measure of baseline functioning. When determining loss of function it is crucial to distinguish 
  
changes which are due to physical impairments from those due to cognitive decline, since 
only the latter are relevant to dementia diagnosis. 
 
 
Delirium 
 
As the main differential diagnosis in the patient in whom dementia is suspected, every 
attempt should be made to exclude delirium before a diagnosis of dementia is made. Highly 
prevalent in the acute hospital setting, delirium affects 29-64% of medical inpatients (Inouye 
et al., 2014) but is underdiagnosed, with 72% of cases going undetected (Collins et al., 
2010). 
 
Delirium is characterised by acute onset, over days or hours, in contrast to the months or 
years suggestive of dementia.  Therefore, informant information about functioning prior to 
the illness leading up to hospital admission is crucial to distinguishing delirium from 
dementia; the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) (Jorm, 
and Jacomb,1989) can be helpful in determining changes in the patient’s cognitive ability 
based on collateral report. Dementia is a major risk factor for delirium and so delirium 
commonly occurs in addition to a pre-existing (but sometimes undiagnosed) dementia. 
Thorough assessment and follow up of these patients should occur, whenever possible, in 
the community setting following discharge. Adequate time must be afforded for resolution of 
delirium in such cases, particularly if other factors likely to influence cognitive impairment are 
implicated. In those with pre-existing dementia, seemingly innocuous factors such as 
constipation, or the distress suffered as a consequence of it, may precipitate or exacerbate 
delirium, often in the absence of derangement of routine blood investigations. Recently 
commenced medications should be closely scrutinised, with anticholinergic or opiate agents 
frequently implicated. No underlying cause for delirium is identified in 10% of cases 
(Rudberg et al., 1997). 
 
Frequent and rapid fluctuations in mental state, in contrast to the more gradual changes 
observed in dementia, are observed in delirium, although fluctuations are also a core feature 
of DLB (McKeith et al., 2005). Visual hallucinations and delusions are also characteristic of 
both DLB and delirium, further underlining the importance of careful exploration of the 
clinical course of such features, preferably with a reliable informant, and a thorough 
neurological examination to assess for the presence of parkinsonian features. 
 
Sustained attention deficits are the hallmark neuropsychological characteristic of delirium 
and a relatively consistent feature during the course of an episode of delirium. Although this 
may be demonstrated through impairment in the MMSE’s “serial sevens” task or the 
attentional subsection of the ACE-R, the presence of severe attentional deficits may make it 
difficult for either to be completed. 
 
Delirium usually resolves within a few days to weeks, although in many cases resolution can 
take up to six months.  However, there is growing evidence that delirium is not as transient 
and benign as previously thought, with recent evidence showing that delirium increases the 
risk of developing dementia eightfold (Davis et al., 2012).   
 
Depression 
 
Depressive illness is an important consideration as a non-cognitive feature of dementia, as a 
differential diagnosis for dementia, and as a risk factor for dementia (Bennett and Thomas, 
2014); late-onset depression is associated with a twofold increased risk of developing 
dementia (Ownby et al., 2006).  
 
  
It is well recognised that cognitive impairment is a core feature of depressive illness in 
patients of any age and such deficits are more severe in late-life depression (Thomas et al., 
2009). Whilst consideration should therefore be given to the possible presence of 
depression, only when depression is itself severe is the cognitive impairment likely to be 
confused with dementia.   
 
Whilst depression is commonly observed as a feature of both VaD and DLB, other features 
of dementia subtypes can also be mistaken for presentations of mood disorders. 
Spontaneous, short-lived episodes of weeping or elevated mood can suggest the presence 
of emotional lability associated with cerebrovascular disease, while elevated mood can be 
indicative of frontal dementias. Apathy is prevalent in all subtypes, even at the early stages 
(Mega et al., 1996) and is frequently mistaken for depression; they should be distinguished 
by the presence of sadness and anhedonia in depression.  
 
Physical examination & investigations 
 
Patients with suspected dementia should undergo thorough physical examination, with 
particular scrutiny paid to the neurological assessment; not only to determine the presence 
of reversible dementias, but also to recognise the characteristics of dementia subtypes such 
as DLB and FTD. 
 
Spontaneous parkinsonism, a core feature of DLB, should encourage examination of 
pyramidal and extra-pyramidal motor systems, which might also determine evidence of VaD 
or amylotrophic lateral sclerosis motor neurone disease. Myoclonus may indicate epilepsy or 
Creuztfeldt-Jacob disease. Gait assessment can identify a shuffling gait (DLB) as well as the 
broad-based gait of normal pressure hydrocephalus, while examination and characterisation 
of any tremors can also be invaluable in determining underlying pathology. Frontal gait 
ataxia may indicate the diagnosis of VaD. 
 
Reflexes are often challenging to assess in patients with cognitive impairment, but the 
characteristic presence of primitive reflexes (grasp, sucking and snout reflexes) in frontal 
dementias can be a helpful diagnostic sign, although they are common in advanced 
dementia of all subtypes. Sensory examination, also difficult to determine in 
patients with cognitive impairment, may reveal abnormalities suggestive of cerebrovascular 
lesions, peripheral diabetic neuropathy or vitamin B12 deficiency, as well as the important, if 
rarer, subacute combined degeneration of the spinal cord.  
 
Full blood count, erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP), 
renal function, thyroid function, calcium, glucose, vitamin B12, serum folate, and liver 
function tests are helpful prior to secondary referral as a means of excluding systemic 
illnesses that might cause, or exacerbate, cognitive impairment. Other tests, such as fasting 
lipids, syphilis serology, HIV testing, mid-stream urine, chest X-ray and electrocardiography 
are used if indicated by clinical findings, rather than forming part of an initial screen. 
 
The National Institute for Clinical Excellence (2006) advocate the use of computed 
tomography (CT) or magnetic resonance imaging (MRI) for exclusion of intracranial 
pathology like tumours, normal pressure hydrocephalus and subdural haematomas. MRI can 
also be useful in providing coronal views of the hippocampi that allow the identification of the 
atrophy characteristic of AD; modern CT scanners can often provide coronal reconstructions 
of the hippocampi to help in the same way.  MRI can also be helpful in detecting more subtle 
neuropathological changes, like frontal lobe atrophy, suggestive of FTD, and 
cerebrovascular disease in the white matter, like lacunar infarcts and ischaemic white matter 
disease. 
 
Functional perfusion imaging with single photon emission computed tomography (SPECT) 
  
and Positron emission tomography (PET) where available, can highlight characteristic 
patterns for the different pathological causes of dementia, but are advisable only after 
consultation with specialist dementia services. 
 
 
Conclusions 
 
Dementia diagnosis in the acute inpatient environment is challenging, particularly given the 
high prevalence of delirium amongst medical admissions, and accessing local specialist 
services following discharge is strongly advised. A comprehensive clinical history, built 
around the framework of identifying cognitive impairment in two domains and functional 
impairment sufficient to interfere with independence, and the exclusion of a diagnosis of 
delirium, provides the most effective approach to dementia diagnosis, after which 
subcategorization subtype diagnosis may follow. 
 
 
 
Key Points 
 
- dementia is characterised by cognitive impairment, representing a decline in previous 
abilities, adversely affecting everyday functioning, and differentiated from delirium 
- the presence of depression, and its relationship to cognitive impairment,  should also 
be considered; 
- a thorough clinical history with access to a reliable informant is crucial and referral to 
specialist memory services recommended; 
- amnesia, whilst common in AD, need not be present for dementia diagnosis to be 
applicable; rather, impairment in two of five cognitive domains; 
- after identification of “all-cause dementia”, subcategorisation subtype diagnosis may 
follow. 
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